Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccination in ACS and CHF
NCT05232292Phase 4Unknown
- Sponsor
- Samara Regional Cardiology Dispensary
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Ultrix Quadri in acute coronary syndrome (ACS), chronic heart failure (CHF), sponsored by Samara Regional Cardiology Dispensary. Status: unknown.
02
Drugs
Ultrix Quadri
03
Conditions
acute coronary syndrome (ACS)chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT05232292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232292.